Cedara Software faces Nasdaq delisting

Article

The common stock of software developer Cedara could be barred from trading on the Nasdaq exchange unless company officials can convince regulators otherwise. Executives of the Canadian company were notified Jan. 9 that Cedara does not comply with either

The common stock of software developer Cedara could be barred from trading on the Nasdaq exchange unless company officials can convince regulators otherwise. Executives of the Canadian company were notified Jan. 9 that Cedara does not comply with either the net tangible assets or minimum stockholders' equity requirements for continued listing on the exchange. The company intends to request a hearing before a Nasdaq listing qualifications panel to review the decision.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Diagnostic Imaging’s Weekly Scan: October 5 — October 11
Current Insights on Interoperability, Enterprise Imaging and AI Integration in Radiology
A Closer Look at the Mammo Enhance Heart Program: An Interview with Arthy Saravanan, MD
© 2025 MJH Life Sciences

All rights reserved.